In this review article (Cancer Prev Res 2013;6:387–400), which was published in the May 2013 issue of Cancer Prevention Research (1), the text within Table 1, a list of completed clinical trials using curcumin, contained a typographical error pertaining to curcumin dosage. Specifically, Table 1 referred to a phase II clinical trial conducted by Cruz-Correa and colleagues, with the following description: “Patients: 5, Oral curcumin 480 g + quercetin 20 mg t.i.d. for 180 days.” The text incorrectly reported curcumin dosage in grams rather than milligrams. With this correction, the affected portion of Table 1 now accurately reads, “Patients: 5, Oral curcumin 480 mg + quercetin 20 mg t.i.d. for 180 days.”
The online version of the article has been corrected and therefore no longer matches the print version. The authors regret this error.
RSS Feeds